Sinopharm
1099.HK
#2702
Rank
C$9.22 B
Marketcap
C$2.96
Share price
-2.73%
Change (1 day)
-7.62%
Change (1 year)
The Sinopharm Group is a Chinese pharmaceutical company that researches, develops, produces, sells and markets pharmaceuticals and other health products.

EPS for Sinopharm (1099.HK)

EPS in 2024 (TTM): C$0.08615

According to Sinopharm's latest financial reports the company's current EPS (TTM) is C$0.46. In 2025 the company made an earnings per share (EPS) of C$0.46 an increase over its 2024 EPS that were of C$0.44.

EPS history for Sinopharm from 2006 to 2024

Annual EPS

Year EPS Change
2025C$0.465.7%
2024C$0.44-24.52%
2023C$0.583.65%
2022C$0.561.3%
2021C$0.5510.33%
2020C$0.5017.26%
2019C$0.435.44%
2018C$0.41-0.87%
2017C$0.4119.44%
2016C$0.3415.3%
2015C$0.3017.06%
2014C$0.2521.9%
2013C$0.2111.82%
2012C$0.1925.24%
2011C$0.1531.02%
2010C$0.113.3%
2009C$0.1146.85%
2008C$0.0747667.57%
2007C$0.04462310.24%
2006C$0.01088